Hayley R. C. Shanks

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial”.

p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial

Nature Medicine(2024)10.1038/s41591-024-02977-w

N/A

0.941DataRank · unranked

57 citations

Kewei Chen, Eric M. Reiman, Kaj Blennow, Jeffrey L. Cummings, Stephen M. Massa +5 more

Serum unsaturated phosphatidylcholines predict longitudinal basal forebrain degeneration in Alzheimer’s disease

Brain Communications(2022)10.1093/braincomms/fcac318

N/A

0.425DataRank · unranked

16 citations

Kate M. Onuska, Dinesh Kumar Barupal, Taylor W. Schmitz, for the Alzheimer’s Disease Neuroimaging Initiative, Hayley R. C. Shanks